hsa-mir-487b: Hsa-mir-487b is a microRNA (miRNA) that has been studied in various contexts [PMC4784328]. It has been found to have a fold change close to significance in relation to relapse versus control in certain conditions [PMC4784328]. In the context of glioblastoma multiforme (GBM) and Alzheimer's disease (AD), hsa-mir-487b is one of the miRNAs that show differential expression [PMC9965735]. It has also been identified as one of the fragil miRNAs and found to have a significant hazard ratio [PMC3002314]. However, it is worth noting that hsa-mir-487b has not been validated through biological experiments [PMC8082881]. In the context of distinguishing different types of lymphoma, hsa-mir-487b is one of the miRNAs used in discriminant functions [PMC4335255]. Hsa-mir-487b has also been found to regulate the expression of target genes involved in various biological processes [PMC9777571]. It has been analyzed alongside other miRNAs in different studies [PMC9270956, PMC6682788, PMC6254589, PMC5223123]. Hsa-mir-487b is more widely expressed in endothelial and muscle cells, including cancer cells [PMC5223123]. In relation to AD, hsa-mir-487b interacts with the AD pathway and targets different genes involved in this disease [PMC6682788]. Additionally, hsa-mir-487b has been identified as one of the potential predictors for patient survival and as having a role in cancer stem cells function [PMC5601660, PMC3629228, PMC3241557].